Pancytopenia After Allogeneic Bone Marrow Transplant Due to Copper Deficiency

被引:3
|
作者
Hudspeth, Michelle [1 ]
Turner, Amy [2 ]
Miller, Nicole [3 ]
Lazarchick, John [3 ]
机构
[1] Med Univ S Carolina, Dept Pediat, Div Pediat Hematol Oncol, Charleston, SC 29425 USA
[2] Med Univ S Carolina, Coll Med, Charleston, SC 29425 USA
[3] Med Univ S Carolina, Dept Pathol, Charleston, SC 29425 USA
关键词
myelodysplasia; pancytopenia; copper deficiency; zinc toxicity; MYELODYSPLASIA; ANEMIA; MICE;
D O I
10.1097/MPH.0b013e318290c644
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Pancytopenia occurring 1 year or later after allogeneic bone marrow transplantation typically prompts a primary consideration for relapse. We present the case of a 15-year old-girl who underwent transplantation for therapy-related myelodysplasia secondary to Ewing sarcoma treatment who developed pancytopenia with myelodysplasia 1 year after transplant due to copper deficiency. Copper deficiency is an important consideration in the evaluation of pancytopenia and myelodysplasia in pediatric patients.
引用
下载
收藏
页码:316 / 318
页数:3
相关论文
共 50 条
  • [21] SEVERE PANCYTOPENIA DUE TO COPPER DEFICIENCY - CASE-REPORT
    RUOCCO, L
    BALDI, A
    CECCONI, N
    MARINI, A
    AZZARA, A
    AMBROGI, F
    GRASSI, B
    ACTA HAEMATOLOGICA, 1986, 76 (04) : 224 - 226
  • [22] Extramedullary relapse without bone marrow involvement after allogeneic bone marrow transplant: A single centre experience
    Andreini, A.
    Di Bella, R.
    Tecchio, C.
    Tinelli, M.
    Ruggeri, G.
    Sorio, M.
    de Sabata, D.
    Ledro, S.
    Pizzolo, G.
    Benedetti, F.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 103 - 104
  • [23] Allogeneic bone marrow transplant for multiple myeloma
    Russell, NH
    Miflin, G
    Stainer, C
    McQuaker, JG
    Bienz, N
    Haynes, AP
    Bessell, EM
    BLOOD, 1997, 89 (07) : 2610 - 2611
  • [24] Allogeneic bone marrow transplant in a child with thalassaemia
    Gooneratne, L. V.
    Dissanayake, R.
    Jayawardena, A.
    Jayaweera, G.
    Abayadeera, A.
    Samarasinghe, M.
    Chandrasiri, P.
    Dissanayake, V. H. W.
    Weerasinghe, T.
    Brambilla, C. Z.
    Manna, N.
    Faulkner, L. B.
    CEYLON MEDICAL JOURNAL, 2015, 60 (02) : 74 - +
  • [25] Marrow and circulating LTC-ICs are decreased after allogeneic bone marrow transplant.
    Selleri, C
    Maciejewski, JP
    Raiola, A
    Risitano, AM
    DelVecchio, L
    Luciano, L
    DeRosa, G
    Rotoli, B
    BLOOD, 1997, 90 (10) : 1660 - 1660
  • [26] OUTCOME AFTER ALLOGENEIC BONE-MARROW TRANSPLANT FOR LEUKEMIA IN OLDER ADULTS
    RINGDEN, O
    HOROWITZ, MM
    GALE, RP
    BIGGS, JC
    GAJEWSKI, J
    RIMM, AA
    SPECK, B
    VEUMSTONE, JA
    DEWITTE, T
    BORTIN, MM
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1993, 270 (01): : 57 - 60
  • [27] Persistence of HIV After Allogeneic Bone Marrow Transplant in a Dually Infected Individual
    Capoferri, Adam A.
    Redd, Andrew D.
    Gocke, Christopher D.
    Clark, Laura R.
    Ambinder, Richard F.
    Durand, Christine M.
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2022, 38 (01) : 33 - 36
  • [28] Immune therapy of metastatic melanoma developing after allogeneic bone marrow transplant
    Cecchini, Michael
    Sznol, Mario
    Seropian, Stuart
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2015, 3
  • [29] PREVENTION AND TREATMENT OF CMV INFECTION AFTER ALLOGENEIC BONE-MARROW TRANSPLANT
    GLUCKMAN, E
    TRAINEAU, R
    DEVERGIE, A
    ESPEROUBOURDEAU, H
    HIRSCH, I
    ANNALS OF HEMATOLOGY, 1992, 64 : A158 - A161
  • [30] Pancytopenia due to massive bone marrow carcinomatosis after radiotherapy for locally advanced breast cancer
    Hama, Yukihiro
    Tate, Etsuko
    INTERNATIONAL CANCER CONFERENCE JOURNAL, 2020, 9 (02) : 52 - 54